Global Rna Therapeutics Market Research Report 2025(Status and Outlook)
Description
Report Overview
RNA therapeutics represent a rapidly evolving class of treatments that utilize RNA molecules—such as messenger RNA (mRNA), small interfering RNA (siRNA), antisense oligonucleotides (ASOs), and microRNA (miRNA)—to modulate gene expression, silence disease-causing genes, or produce therapeutic proteins. These therapies offer precision targeting of genetic and protein-based diseases, including cancer, rare genetic disorders, infectious diseases, and cardiovascular conditions. The market has gained significant momentum following the success of mRNA-based COVID-19 vaccines, demonstrating the potential for rapid development and scalability. Key players include biotech firms like Moderna, BioNTech, and Alnylam, alongside pharmaceutical giants such as Pfizer and Roche, which are investing heavily in RNA-based drug development. The market is driven by advancements in delivery technologies (e.g., lipid nanoparticles), increasing genetic research funding, and growing demand for personalized medicine. However, challenges such as stability, immunogenicity, and high development costs remain hurdles. With a projected compound annual growth rate (CAGR) of over 15% from 2023 to 2030, the RNA therapeutics market is poised for expansion, particularly in oncology and rare diseases, supported by regulatory incentives and accelerating clinical trials.
The global Rna Therapeutics market size was estimated at USD 2002.2 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Rna Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rna Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rna Therapeutics market.
Global Rna Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Moderna
Alnylam Pharmaceuticals
Novartis
Ionis Pharmaceuticals
Sarepta Therapeutics
Sanofi
Pfizer
Arrowhead Pharmaceuticals
BioNTech
Orna Therapeutics
CRISPR Therapeutics
Silence Therapeutics
Astellas Pharma Inc.
CureVac
Sirnaomics
Arcturus Therapeutics
Arbutus Biopharma
Market Segmentation (by Type)
mRNA
RNA Interference (RNAi)
Antisense Oligonucleotide (ASO)
Other
Market Segmentation (by Application)
Hospitals
Research Institutions
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Rna Therapeutics Market
Overview of the regional outlook of the Rna Therapeutics Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rna Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rna Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
RNA therapeutics represent a rapidly evolving class of treatments that utilize RNA molecules—such as messenger RNA (mRNA), small interfering RNA (siRNA), antisense oligonucleotides (ASOs), and microRNA (miRNA)—to modulate gene expression, silence disease-causing genes, or produce therapeutic proteins. These therapies offer precision targeting of genetic and protein-based diseases, including cancer, rare genetic disorders, infectious diseases, and cardiovascular conditions. The market has gained significant momentum following the success of mRNA-based COVID-19 vaccines, demonstrating the potential for rapid development and scalability. Key players include biotech firms like Moderna, BioNTech, and Alnylam, alongside pharmaceutical giants such as Pfizer and Roche, which are investing heavily in RNA-based drug development. The market is driven by advancements in delivery technologies (e.g., lipid nanoparticles), increasing genetic research funding, and growing demand for personalized medicine. However, challenges such as stability, immunogenicity, and high development costs remain hurdles. With a projected compound annual growth rate (CAGR) of over 15% from 2023 to 2030, the RNA therapeutics market is poised for expansion, particularly in oncology and rare diseases, supported by regulatory incentives and accelerating clinical trials.
The global Rna Therapeutics market size was estimated at USD 2002.2 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Rna Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rna Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rna Therapeutics market.
Global Rna Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Moderna
Alnylam Pharmaceuticals
Novartis
Ionis Pharmaceuticals
Sarepta Therapeutics
Sanofi
Pfizer
Arrowhead Pharmaceuticals
BioNTech
Orna Therapeutics
CRISPR Therapeutics
Silence Therapeutics
Astellas Pharma Inc.
CureVac
Sirnaomics
Arcturus Therapeutics
Arbutus Biopharma
Market Segmentation (by Type)
mRNA
RNA Interference (RNAi)
Antisense Oligonucleotide (ASO)
Other
Market Segmentation (by Application)
Hospitals
Research Institutions
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Rna Therapeutics Market
Overview of the regional outlook of the Rna Therapeutics Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rna Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rna Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
158 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Rna Therapeutics
- 1.2 Key Market Segments
- 1.2.1 Rna Therapeutics Segment by Type
- 1.2.2 Rna Therapeutics Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Rna Therapeutics Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Rna Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Rna Therapeutics Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Rna Therapeutics Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Rna Therapeutics Product Life Cycle
- 3.3 Global Rna Therapeutics Sales by Manufacturers (2020-2025)
- 3.4 Global Rna Therapeutics Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Rna Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Rna Therapeutics Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Rna Therapeutics Market Competitive Situation and Trends
- 3.8.1 Rna Therapeutics Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Rna Therapeutics Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Rna Therapeutics Industry Chain Analysis
- 4.1 Rna Therapeutics Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Rna Therapeutics Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Rna Therapeutics Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Rna Therapeutics Market
- 5.7 ESG Ratings of Leading Companies
- 6 Rna Therapeutics Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Rna Therapeutics Sales Market Share by Type (2020-2025)
- 6.3 Global Rna Therapeutics Market Size Market Share by Type (2020-2025)
- 6.4 Global Rna Therapeutics Price by Type (2020-2025)
- 7 Rna Therapeutics Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Rna Therapeutics Market Sales by Application (2020-2025)
- 7.3 Global Rna Therapeutics Market Size (M USD) by Application (2020-2025)
- 7.4 Global Rna Therapeutics Sales Growth Rate by Application (2020-2025)
- 8 Rna Therapeutics Market Sales by Region
- 8.1 Global Rna Therapeutics Sales by Region
- 8.1.1 Global Rna Therapeutics Sales by Region
- 8.1.2 Global Rna Therapeutics Sales Market Share by Region
- 8.2 Global Rna Therapeutics Market Size by Region
- 8.2.1 Global Rna Therapeutics Market Size by Region
- 8.2.2 Global Rna Therapeutics Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Rna Therapeutics Sales by Country
- 8.3.2 North America Rna Therapeutics Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Rna Therapeutics Sales by Country
- 8.4.2 Europe Rna Therapeutics Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Rna Therapeutics Sales by Region
- 8.5.2 Asia Pacific Rna Therapeutics Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Rna Therapeutics Sales by Country
- 8.6.2 South America Rna Therapeutics Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Rna Therapeutics Sales by Region
- 8.7.2 Middle East and Africa Rna Therapeutics Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Rna Therapeutics Market Production by Region
- 9.1 Global Production of Rna Therapeutics by Region(2020-2025)
- 9.2 Global Rna Therapeutics Revenue Market Share by Region (2020-2025)
- 9.3 Global Rna Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Rna Therapeutics Production
- 9.4.1 North America Rna Therapeutics Production Growth Rate (2020-2025)
- 9.4.2 North America Rna Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Rna Therapeutics Production
- 9.5.1 Europe Rna Therapeutics Production Growth Rate (2020-2025)
- 9.5.2 Europe Rna Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Rna Therapeutics Production (2020-2025)
- 9.6.1 Japan Rna Therapeutics Production Growth Rate (2020-2025)
- 9.6.2 Japan Rna Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Rna Therapeutics Production (2020-2025)
- 9.7.1 China Rna Therapeutics Production Growth Rate (2020-2025)
- 9.7.2 China Rna Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Moderna
- 10.1.1 Moderna Basic Information
- 10.1.2 Moderna Rna Therapeutics Product Overview
- 10.1.3 Moderna Rna Therapeutics Product Market Performance
- 10.1.4 Moderna Business Overview
- 10.1.5 Moderna SWOT Analysis
- 10.1.6 Moderna Recent Developments
- 10.2 Alnylam Pharmaceuticals
- 10.2.1 Alnylam Pharmaceuticals Basic Information
- 10.2.2 Alnylam Pharmaceuticals Rna Therapeutics Product Overview
- 10.2.3 Alnylam Pharmaceuticals Rna Therapeutics Product Market Performance
- 10.2.4 Alnylam Pharmaceuticals Business Overview
- 10.2.5 Alnylam Pharmaceuticals SWOT Analysis
- 10.2.6 Alnylam Pharmaceuticals Recent Developments
- 10.3 Novartis
- 10.3.1 Novartis Basic Information
- 10.3.2 Novartis Rna Therapeutics Product Overview
- 10.3.3 Novartis Rna Therapeutics Product Market Performance
- 10.3.4 Novartis Business Overview
- 10.3.5 Novartis SWOT Analysis
- 10.3.6 Novartis Recent Developments
- 10.4 Ionis Pharmaceuticals
- 10.4.1 Ionis Pharmaceuticals Basic Information
- 10.4.2 Ionis Pharmaceuticals Rna Therapeutics Product Overview
- 10.4.3 Ionis Pharmaceuticals Rna Therapeutics Product Market Performance
- 10.4.4 Ionis Pharmaceuticals Business Overview
- 10.4.5 Ionis Pharmaceuticals Recent Developments
- 10.5 Sarepta Therapeutics
- 10.5.1 Sarepta Therapeutics Basic Information
- 10.5.2 Sarepta Therapeutics Rna Therapeutics Product Overview
- 10.5.3 Sarepta Therapeutics Rna Therapeutics Product Market Performance
- 10.5.4 Sarepta Therapeutics Business Overview
- 10.5.5 Sarepta Therapeutics Recent Developments
- 10.6 Sanofi
- 10.6.1 Sanofi Basic Information
- 10.6.2 Sanofi Rna Therapeutics Product Overview
- 10.6.3 Sanofi Rna Therapeutics Product Market Performance
- 10.6.4 Sanofi Business Overview
- 10.6.5 Sanofi Recent Developments
- 10.7 Pfizer
- 10.7.1 Pfizer Basic Information
- 10.7.2 Pfizer Rna Therapeutics Product Overview
- 10.7.3 Pfizer Rna Therapeutics Product Market Performance
- 10.7.4 Pfizer Business Overview
- 10.7.5 Pfizer Recent Developments
- 10.8 Arrowhead Pharmaceuticals
- 10.8.1 Arrowhead Pharmaceuticals Basic Information
- 10.8.2 Arrowhead Pharmaceuticals Rna Therapeutics Product Overview
- 10.8.3 Arrowhead Pharmaceuticals Rna Therapeutics Product Market Performance
- 10.8.4 Arrowhead Pharmaceuticals Business Overview
- 10.8.5 Arrowhead Pharmaceuticals Recent Developments
- 10.9 BioNTech
- 10.9.1 BioNTech Basic Information
- 10.9.2 BioNTech Rna Therapeutics Product Overview
- 10.9.3 BioNTech Rna Therapeutics Product Market Performance
- 10.9.4 BioNTech Business Overview
- 10.9.5 BioNTech Recent Developments
- 10.10 Orna Therapeutics
- 10.10.1 Orna Therapeutics Basic Information
- 10.10.2 Orna Therapeutics Rna Therapeutics Product Overview
- 10.10.3 Orna Therapeutics Rna Therapeutics Product Market Performance
- 10.10.4 Orna Therapeutics Business Overview
- 10.10.5 Orna Therapeutics Recent Developments
- 10.11 CRISPR Therapeutics
- 10.11.1 CRISPR Therapeutics Basic Information
- 10.11.2 CRISPR Therapeutics Rna Therapeutics Product Overview
- 10.11.3 CRISPR Therapeutics Rna Therapeutics Product Market Performance
- 10.11.4 CRISPR Therapeutics Business Overview
- 10.11.5 CRISPR Therapeutics Recent Developments
- 10.12 Silence Therapeutics
- 10.12.1 Silence Therapeutics Basic Information
- 10.12.2 Silence Therapeutics Rna Therapeutics Product Overview
- 10.12.3 Silence Therapeutics Rna Therapeutics Product Market Performance
- 10.12.4 Silence Therapeutics Business Overview
- 10.12.5 Silence Therapeutics Recent Developments
- 10.13 Astellas Pharma Inc.
- 10.13.1 Astellas Pharma Inc. Basic Information
- 10.13.2 Astellas Pharma Inc. Rna Therapeutics Product Overview
- 10.13.3 Astellas Pharma Inc. Rna Therapeutics Product Market Performance
- 10.13.4 Astellas Pharma Inc. Business Overview
- 10.13.5 Astellas Pharma Inc. Recent Developments
- 10.14 CureVac
- 10.14.1 CureVac Basic Information
- 10.14.2 CureVac Rna Therapeutics Product Overview
- 10.14.3 CureVac Rna Therapeutics Product Market Performance
- 10.14.4 CureVac Business Overview
- 10.14.5 CureVac Recent Developments
- 10.15 Sirnaomics
- 10.15.1 Sirnaomics Basic Information
- 10.15.2 Sirnaomics Rna Therapeutics Product Overview
- 10.15.3 Sirnaomics Rna Therapeutics Product Market Performance
- 10.15.4 Sirnaomics Business Overview
- 10.15.5 Sirnaomics Recent Developments
- 10.16 Arcturus Therapeutics
- 10.16.1 Arcturus Therapeutics Basic Information
- 10.16.2 Arcturus Therapeutics Rna Therapeutics Product Overview
- 10.16.3 Arcturus Therapeutics Rna Therapeutics Product Market Performance
- 10.16.4 Arcturus Therapeutics Business Overview
- 10.16.5 Arcturus Therapeutics Recent Developments
- 10.17 Arbutus Biopharma
- 10.17.1 Arbutus Biopharma Basic Information
- 10.17.2 Arbutus Biopharma Rna Therapeutics Product Overview
- 10.17.3 Arbutus Biopharma Rna Therapeutics Product Market Performance
- 10.17.4 Arbutus Biopharma Business Overview
- 10.17.5 Arbutus Biopharma Recent Developments
- 11 Rna Therapeutics Market Forecast by Region
- 11.1 Global Rna Therapeutics Market Size Forecast
- 11.2 Global Rna Therapeutics Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Rna Therapeutics Market Size Forecast by Country
- 11.2.3 Asia Pacific Rna Therapeutics Market Size Forecast by Region
- 11.2.4 South America Rna Therapeutics Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Rna Therapeutics by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Rna Therapeutics Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Rna Therapeutics by Type (2026-2033)
- 12.1.2 Global Rna Therapeutics Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Rna Therapeutics by Type (2026-2033)
- 12.2 Global Rna Therapeutics Market Forecast by Application (2026-2033)
- 12.2.1 Global Rna Therapeutics Sales (K MT) Forecast by Application
- 12.2.2 Global Rna Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.